Archive | Evercyte GmbH

Home / Archive

CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation

Tuesday 25th February 2020

By Evercyte GmbH Learn More >

Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting

Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting

Thursday 14th November 2019

By Evercyte GmbH Learn More >

Evercyte bringing latest cell-based advances to BIO-Europe Hamburg

Monday 28th October 2019

By Evercyte GmbH Learn More >

Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama

Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama

Wednesday 2nd October 2019

By Evercyte GmbH Learn More >

Evercyte brings new EV research focus to BIO 2019 Philadelphia

Evercyte brings new EV research focus to BIO 2019 Philadelphia

Wednesday 29th May 2019

By Evercyte GmbH Learn More >

Evercyte brings new EV research focus to ESACT Copenhagen

Evercyte brings new EV research focus to ESACT Copenhagen

Tuesday 30th April 2019

By Evercyte GmbH Learn More >

Evercyte brings new extracellular vesicle research focus to ISEV Kyoto

Wednesday 10th April 2019

By Evercyte GmbH Learn More >

Cryopreservation of hTEC/SVTERT24-B cells – Protocol

Thursday 28th March 2019

By Evercyte GmbH Learn More >

In vitro propagation of hTEC/SVTERT24-B cells – Protocol

Thursday 28th March 2019

By Evercyte GmbH Learn More >

Human Renal Proximal Tubular Epithelial Cells (RPTEC/TERT1) – Key Publications

Thursday 28th February 2019

By Evercyte GmbH Learn More >

In vitro propagation of RPTEC/TERT1 cells – Protocol

Thursday 28th February 2019

By Evercyte GmbH Learn More >

Human Urine-derived podocytes, hTERT and SV40 early region immortalized – PODO/SVTERT152

Monday 25th February 2019

By Evercyte GmbH Learn More >